Claudia P Miller
7PUBLICATIONS
82CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jan 26, 2026
FDA Approval Summary: Tarlatamab for the Treatment of Extensive-Stage Small Cell Lung Cancer.Yufan Liu, Jeannette Nashed, Amy K Barone
|Sep 05, 2025
FDA Approval Summary: Vorasidenib for IDH-Mutant Grade 2 Astrocytoma or Oligodendroglioma Following Surgery.Michael I Barbato, Amy K Barone, Stephanie L Aungst
|Aug 27, 2025
FDA Approval Summary: Datopotamab Deruxtecan-dlnk for Treatment of Patients with Unresectable or Metastatic, HR-Positive, HER2-Negative Breast Cancer.Melanie Royce, Mirat Shah, Lijun Zhang
|Jan 14, 2025
FDA Approval Summary: Tovorafenib for Relapsed or Refractory BRAF-Altered Pediatric Low-Grade Glioma.Sonia Singh, Diana Bradford, Somak Chatterjee
|Jun 14, 2024
FDA Approval Summary: Repotrectinib for Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer.Michael I Barbato, Diana Bradford, Yi Ren
|Aug 25, 2023
FDA Approval Summary: Alpelisib for PIK3CA-Related Overgrowth Spectrum.Sonia Singh, Diana Bradford, Xiaoxue Li
Pageof 2
Frequent Collaborators
7 joint publications
Richard Pazdur
5 joint publications
Paul G Kluetz
5 joint publications
Youwei Bi
4 joint publications
Shenghui Tang
4 joint publications
Diana Bradford
4 joint publications
Harpreet Singh
4 joint publications
Nicole Drezner
4 joint publications
Hong Zhao
4 joint publications
Barbara Scepura
3 joint publications
Anup K Amatya
